Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Biochim Biophys Acta. 2013 Apr 22;1836(1):158–165. doi: 10.1016/j.bbcan.2013.04.003

Table 1.

Transgenic and genetically engineered mouse models for glioblastoma multiforme

Mouse Model Significant Findings References
RCAS-EGFR; tva-INK4a-ARF−/−
RCAS-EGFR; tva-INK4a-ARF+/−
EGFR mutation alone is insufficient to induce glioma unless the loss of INK4a-ARF occurs concomitantly Holland, 2000
GFAP-V12Ha-ras; GFAP-EGFRVIII Aberrant EGFR level is involved in glioma progression rather than initiation and it can give rise to both astrocytoma & oligodendrocytoma Wei, 2006
S100β-V-erb(EGFR); S100β-INK4a- ARF−/−
S100β-V-erb(EGFR); S100β-INK4a- ARF+/−
Rapid tumor development from low-grade to high-grade with shorter latency and increased penetration Weiss, 2003
CAGGS-Cre; EGFRVIII; INK4a−/−; PTEN−/− EGFRVIII alone is insufficient to induce cell transformation and only when concomitant loss of tumor suppresser gene INK4a along with PTEN can promote a fully-penetrant, rapid onset malignant glioma that resembles to human GBM Zhu, 2009
TgG(ΔZ)T121; PTEN−/− (pRB inactivated through T21 expression) PTEN inactivation in pRB-inactivated model gives rise to focal hypercellularity, enhancing astrocytoma invasiveness as well as promoting angiogenesis Xiao, 2005
RCAS-KRas; PTEN−/− The mice display similar histopathological characteristics such as increased cell density, pseudopalisading necrosis, microvascular proliferation Hu, 2005
p53−/−; Nf1−/−; PTEN+/− Heterozygosities of PTEN, Nf1 and p53 cause accelerated glioma formation similar to primary “de novo” GBM Kwon, 2008
Ntva-INK4a-ARF+/−; RCAS-KRas; RCAS-AKT The deletion of INK4a-ARF locus in addition to the activation of KRas and AKT permits GBM formation from differentiated astrocytes as well as enhances gliomageneis from neural progenitors. Uhrbom, 2002
Nf1+/−; p53+/− The mouse model displays different stages of glioma including GBM. Reilly, 2000
P53 −/−; Nf1−/−; GFAP-Cre
P53+/−; Nf1−/−; GFAP-Cre
P53+/−; Nf1+/−; GFAP-Cre
TP53 loss prior to or concomitant to Nf1 loss is required for malignant astrocytoma formation when early loss of Nf1 fails to induce gliomagenesis Zhu, 2011